Institute for International Research

Morning Coffee and Chairperson's Day One Recap

Co-Chair: Whaijen Soo, MD, PhD Senior Vice President of Medical Research
BIOGEN IDEC

Creating a Standardized Approach and Tackling the Challenges of Microdosing

Stephen R. Dueker, PhD CEO VITALEA SCIENCE

KEYNOTE SPEAKER
From the Patient Perspective

Hamilton Jordan Bestselling Author of "No Such Thing As a Bad Day",
former White House Chief of Staff under President Carter and Co-Founder of Unity 08

Part I-Process, Approach and Standards - Learning from the TeGenero & Parexel TGN1412 London Phase I Study

Part II - Overseas Phase I Trials: Examining the Status and Future of Partnerships Abroad

Francis P. Crawley Director General
GOOD CLINICAL PRACTICE ALLIANCE

Dealing with IRBs to Promote Timely, Efficient and Compliant Review

Lynn A. Meyer President CIP, CIM,
INTEGREVIEW- ETHICAL REVIEW BOARD

How Exploratory INDs Can Help You Use Less Resources

John Wagner, MD Executive Director, Clinical Pharmacology
MERCK

Steady Enrollment and Optimal Trial Metrics Can Become Reality: The Use of Key Enrollment Optimization Processes, Clinical Investigative Networks and eClinical Processes to Facilitate Cost Effective Clinical Trials

Michael Pozsgai Global Optimization Consultant
ELI LILLY

Lee Scheible, RPh Senior Medical Consultant
ELI LILLY